373 related articles for article (PubMed ID: 20298965)
21. Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels.
Rush AM; Cummins TR
Mol Interv; 2007 Aug; 7(4):192-5, 180. PubMed ID: 17827438
[TBL] [Abstract][Full Text] [Related]
22. Neurological perspectives on voltage-gated sodium channels.
Eijkelkamp N; Linley JE; Baker MD; Minett MS; Cregg R; Werdehausen R; Rugiero F; Wood JN
Brain; 2012 Sep; 135(Pt 9):2585-612. PubMed ID: 22961543
[TBL] [Abstract][Full Text] [Related]
23. [Ion channels and epilepsy].
Armijo JA; de las Cuevas I; Adín J
Rev Neurol; 2000 Jun; 30 Suppl 1():S25-41. PubMed ID: 10904966
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels.
Ziyatdinova S; Gurevicius K; Kutchiashvili N; Bolkvadze T; Nissinen J; Tanila H; Pitkänen A
Epilepsy Res; 2011 Mar; 94(1-2):75-85. PubMed ID: 21300523
[TBL] [Abstract][Full Text] [Related]
25. The role of sodium channels in neuropathic pain.
Rogers M; Tang L; Madge DJ; Stevens EB
Semin Cell Dev Biol; 2006 Oct; 17(5):571-81. PubMed ID: 17123847
[TBL] [Abstract][Full Text] [Related]
26. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall WA
Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
[TBL] [Abstract][Full Text] [Related]
27. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
Abdelsayed M; Sokolov S
Channels (Austin); 2013; 7(3):146-52. PubMed ID: 23531742
[TBL] [Abstract][Full Text] [Related]
28. The up-regulation of voltage-gated sodium channels subtypes coincides with an increased sodium current in hippocampal neuronal culture model.
Guo F; Xu X; Cai J; Hu H; Sun W; He G; Shao D; Wang L; Chen T; Shaw C; Zhu T; Hao L
Neurochem Int; 2013 Feb; 62(3):287-95. PubMed ID: 23333592
[TBL] [Abstract][Full Text] [Related]
29. Voltage-gated sodium channels and hyperalgesia.
Lai J; Porreca F; Hunter JC; Gold MS
Annu Rev Pharmacol Toxicol; 2004; 44():371-97. PubMed ID: 14744251
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels.
Catterall WA; Swanson TM
Mol Pharmacol; 2015 Jul; 88(1):141-50. PubMed ID: 25848093
[TBL] [Abstract][Full Text] [Related]
31. Ion channel targets and treatment efficacy in neuropathic pain.
Markman JD; Dworkin RH
J Pain; 2006 Jan; 7(1 Suppl 1):S38-47. PubMed ID: 16427000
[TBL] [Abstract][Full Text] [Related]
32. Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
Schaub C; Uebachs M; Beck H
Epilepsia; 2007 Jul; 48(7):1339-50. PubMed ID: 17441992
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
Ma X; Poon TY; Wong PT; Chui WK
Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
[TBL] [Abstract][Full Text] [Related]
34. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
35. Seizures and sodium hydrogen exchangers: potential of sodium hydrogen exchanger inhibitors as novel anticonvulsants.
Ali A; Ahmad FJ; Dua Y; Pillai KK; Vohora D
CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):343-7. PubMed ID: 18991662
[TBL] [Abstract][Full Text] [Related]
36. Protein-protein interactions involving voltage-gated sodium channels: Post-translational regulation, intracellular trafficking and functional expression.
Shao D; Okuse K; Djamgoz MB
Int J Biochem Cell Biol; 2009 Jul; 41(7):1471-81. PubMed ID: 19401147
[TBL] [Abstract][Full Text] [Related]
37. An epilepsy mutation in the beta1 subunit of the voltage-gated sodium channel results in reduced channel sensitivity to phenytoin.
Lucas PT; Meadows LS; Nicholls J; Ragsdale DS
Epilepsy Res; 2005 May; 64(3):77-84. PubMed ID: 15922564
[TBL] [Abstract][Full Text] [Related]
38. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
[TBL] [Abstract][Full Text] [Related]
39. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
Tarnawa I; Bölcskei H; Kocsis P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
[TBL] [Abstract][Full Text] [Related]
40. Sodium channel blockers for the treatment of neuropathic pain.
Bhattacharya A; Wickenden AD; Chaplan SR
Neurotherapeutics; 2009 Oct; 6(4):663-78. PubMed ID: 19789071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
